These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10891529)

  • 1. Theophylline and cisplatin synergize in down regulation of BCL-2 induction of apoptosis in human granulosa cells transformed by a mutated p53 (p53 val135) and Ha-ras oncogene.
    Yoshida Y; Hosokawa K; Dantes A; Tajima K; Kotsuji F; Amsterdam A
    Int J Oncol; 2000 Aug; 17(2):227-35. PubMed ID: 10891529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potent peptide antagonist to angiogenesis, C16Y, and cisplatin act synergistically in the down-regulation of the Bcl-2/Bax ratio and the induction of apoptosis in human ovarian cancer cells.
    Shinagawa A; Yoshida Y; Kurokawa T; Horiuchi Y; Tsuyoshi H; Orisaka M; Sawamura Y; Kleinman HK; Kotsuji F
    Int J Oncol; 2011 Dec; 39(6):1359-64. PubMed ID: 21935568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphodiesterase inhibitors as anti-cancer drugs.
    Hirsh L; Dantes A; Suh BS; Yoshida Y; Hosokawa K; Tajima K; Kotsuji F; Merimsky O; Amsterdam A
    Biochem Pharmacol; 2004 Sep; 68(6):981-8. PubMed ID: 15313391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human lymphoblastoid cell lines expressing mutant p53 exhibit decreased sensitivity to cisplatin-induced cytotoxicity.
    Piovesan B; Pennell N; Berinstein NL
    Oncogene; 1998 Nov; 17(18):2339-50. PubMed ID: 9811465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatin inhibits paclitaxel-induced apoptosis in cisplatin-resistant ovarian cancer cell lines: possible explanation for failure of combination therapy.
    Judson PL; Watson JM; Gehrig PA; Fowler WC; Haskill JS
    Cancer Res; 1999 May; 59(10):2425-32. PubMed ID: 10344753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time-dependent changes in factors involved in the apoptotic process in human ovarian cancer cells as a response to cisplatin.
    Kolfschoten GM; Hulscher TM; Schrier SM; van Houten VM; Pinedo HM; Boven E
    Gynecol Oncol; 2002 Mar; 84(3):404-12. PubMed ID: 11855878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
    Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F
    Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cisplatin- and paclitaxel-induced apoptosis of ovarian carcinoma cells and the relationship between bax and bak up-regulation and the functional status of p53.
    Jones NA; Turner J; McIlwrath AJ; Brown R; Dive C
    Mol Pharmacol; 1998 May; 53(5):819-26. PubMed ID: 9584207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of X-linked inhibitor of apoptosis protein induces apoptosis in chemoresistant human ovarian cancer cells.
    Sasaki H; Sheng Y; Kotsuji F; Tsang BK
    Cancer Res; 2000 Oct; 60(20):5659-66. PubMed ID: 11059757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of apoptosis in non-small lung carcinoma cell line (H1299) by combination of anti-asthma drugs with gemcitabine and cisplatin.
    Merimsky O; Hirsh L; Dantes A; Land-Bracha A; Suh BS; Amsterdam A
    Int J Oncol; 2005 Feb; 26(2):475-82. PubMed ID: 15645133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of correlation between cisplatin-induced apoptosis, p53 status and expression of Bcl-2 family proteins in testicular germ cell tumour cell lines.
    Burger H; Nooter K; Boersma AW; Kortland CJ; Stoter G
    Int J Cancer; 1997 Nov; 73(4):592-9. PubMed ID: 9389577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoids protect against apoptosis induced by serum deprivation, cyclic adenosine 3',5'-monophosphate and p53 activation in immortalized human granulosa cells: involvement of Bcl-2.
    Sasson R; Tajima K; Amsterdam A
    Endocrinology; 2001 Feb; 142(2):802-11. PubMed ID: 11159853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Taxol-induced bcl-2 phosphorylation in ovarian cancer cell monolayer and spheroids.
    Makhija S; Taylor DD; Gibb RK; Gerçel-Taylor C
    Int J Oncol; 1999 Mar; 14(3):515-21. PubMed ID: 10024685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oridonin effectively reverses cisplatin drug resistance in human ovarian cancer cells via induction of cell apoptosis and inhibition of matrix metalloproteinase expression.
    Ma S; Tan W; Du B; Liu W; Li W; Che D; Zhang G
    Mol Med Rep; 2016 Apr; 13(4):3342-8. PubMed ID: 26935490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Akt promotes cisplatin resistance in human ovarian cancer cells through inhibition of p53 phosphorylation and nuclear function.
    Fraser M; Bai T; Tsang BK
    Int J Cancer; 2008 Feb; 122(3):534-46. PubMed ID: 17918180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisplatin resistance in an ovarian carcinoma is associated with a defect in programmed cell death control through XIAP regulation.
    Mansouri A; Zhang Q; Ridgway LD; Tian L; Claret FX
    Oncol Res; 2003; 13(6-10):399-404. PubMed ID: 12725530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms underlying the synergistic effect of SU5416 and cisplatin on cytotoxicity in human ovarian tumor cells.
    Zhong X; Li X; Wang G; Zhu Y; Hu G; Zhao J; Neace C; Ding H; Reed E; Li QQ
    Int J Oncol; 2004 Aug; 25(2):445-51. PubMed ID: 15254743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of PUMA-alpha by p53 in cisplatin-induced renal cell apoptosis.
    Jiang M; Wei Q; Wang J; Du Q; Yu J; Zhang L; Dong Z
    Oncogene; 2006 Jul; 25(29):4056-66. PubMed ID: 16491117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenylbutyrate-induced apoptosis and differential expression of Bcl-2, Bax, p53 and Fas in human prostate cancer cell lines.
    Ng AY; Bales W; Veltri RW
    Anal Quant Cytol Histol; 2000 Feb; 22(1):45-54. PubMed ID: 10696460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mouse double minute antagonist Nutlin-3a enhances chemotherapy-induced apoptosis in cancer cells with mutant p53 by activating E2F1.
    Ambrosini G; Sambol EB; Carvajal D; Vassilev LT; Singer S; Schwartz GK
    Oncogene; 2007 May; 26(24):3473-81. PubMed ID: 17146434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.